Navigation Links
Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation
Date:7/22/2009

An Atlanta cosmetic plastic surgeon is the first in the area to offer aesthetic enhancement patients Dysport®, the latest FDA-approved alternative to BOTOX® injections. The injectable facial rejuvenation treatment is designed to reduce the appearance of wrinkles and aging in the face.

(Vocus) July 22, 2009 -- A new injectable treatment similar to the popular BOTOX® Cosmetic has just been approved by the U.S. Food and Drug Administration, and one Atlanta cosmetic surgery practice is the first in the region to use it. Dr. John L. LeRoy is helping Atlanta-area patients reduce the appearance of fine lines and wrinkles with the new Dysport®, licensed by Medicis from French developer Ipsen. Dysport® functions much the same way as BOTOX® injections, and may now be considered one of its main competitors.

Dysport® is a protein derived from Clostridium botulinum, and has been in use in Europe for several years. It’s designed to smooth out frown lines and wrinkles in the face by temporarily preventing facial muscles from contracting. The treatment is highly effective for reducing the appearance of creases and lines on the forehead and between the eyes. Results can last up to six months, and they can be maintained with touch-up treatments.

Injectable cosmetic procedures have become more and more popular since the turn of the 21st century. The procedures are less invasive than facelift surgery and other surgical aesthetic enhancement options, and they typically take less than 30 minutes to perform with minimal to no recovery time. Plus, they offer patients a way to enhance specific areas of the face with more subtle results that can be allowed to dissipate over a period of months, or be maintained with regular treatment sessions as the effects wear off.

Although treatments like Dysport® are often seen as less invasive cosmetic enhancement alternatives, Dr. LeRoy says he also recommends injectable procedures to augment the results for his Atlanta facelift patients. “Even if you have a facelift there are often still a few of those etched lines that don’t go away, injectable treatments can help with those. It gives you a rested look, it doesn’t freeze your face. If it’s done correctly, you should look rested, youthful, and very happy.”

Dr. LeRoy says all aspects of Dysport® and any other cosmetic enhancement procedure he performs, including risks, benefits, and alternatives, are gone over in detail at the initial patient consultation.

About Dr. John L. LeRoy
John L. LeRoy, MD is a board-certified plastic surgeon in Atlanta and a Diplomate of the American Board of Plastic Surgery. Dr. LeRoy is a Fellow of the American College of Surgeons, and is the first in Atlanta to perform Dysport® injections for facial rejuvenation. He is specialty trained in cosmetic surgery, and regularly contributes to professional medical journals such as American Surgeon and Plastic an Reconstructive Surgery. In 1997, Dr. LeRoy developed the original, now famous, Band Aid "Mini" Facelift. In addition, he is highly experienced in an array of plastic surgery procedures including liposuction, facelifts and body contouring.

Dr. LeRoy has lent his expertise to many philanthropic and charitable organizations, including a two-week mission in war-torn Croatia where he acted as a volunteer surgeon treating wounded civilians in the Bosnian conflict.

For more information on Dr. John L. LeRoy, the practice can be reached at 5669 Peachtree Dunwoody Rd. NE, Suite 130, Atlanta, GA 30342 – (404) 843-0840; or via www.atlantafacelift.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/atlanta/prweb2664684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Parsons Announces Start of Wi-Fi Service on Fauntleroy/Vashon/Southworth Ferry Run
2. Band Aid Mini Facelift Developed by Atlanta Plastic Surgeon John L. LeRoy, MD can Help Patients Look Younger for Less Money
3. First biomarker discovered that predicts prostate cancer outcome
4. FDA Approves First Anti-Psychotic for Kids
5. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
6. First study examines newly-licensed RN work attitudes and intentions
7. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
10. High and mighty: first common height gene identified by researchers behind obesity gene finding
11. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology: